31410 Federal Register / Vol. 83, No. 129 / Thursday, July 5, 2018 / Notices 

National Standards for Culturally and 

Linguistically Appropriate Services in 

Health and Health Care at https://

minorityhealth.hhs.gov/omh/ 

browse.aspx?lvl=2&lvlid=53. 

Pursuant to 45 CFR 80.3(d), an 

individual shall not be deemed 

subjected to discrimination by reason of 

his or her exclusion from benefits 

limited by Federal law to individuals 

eligible for benefits and services from 

the IHS. 

Recipients will be required to sign the 

HHS–690 Assurance of Compliance 

form which can be obtained from the 

following website: http://www.hhs.gov/ 

sites/default/files/forms/hhs-690.pdf, 

and send it directly to the: U.S. 

Department of Health and Human 

Services, Office for Civil Rights, 200 

Independence Avenue SW, Room 509F, 

Washington, DC 20201. 

E. Federal Awardee Performance and 

Integrity Information System (FAPIIS) 

The IHS is required to review and 

consider any information about the 

applicant that is in the Federal Awardee 

Performance and Integrity Information 

System (FAPIIS) before making any 

award in excess of the simplified 

acquisition threshold (currently 

$150,000) over the period of 

performance. An applicant may review 

and comment on any information about 

itself that a Federal awarding agency 

previously entered. The IHS will 

consider any comments by the 

applicant, in addition to other 

information in FAPIIS in making a 

judgment about the applicant’s integrity, 

business ethics, and record of 

performance under Federal awards 

when completing the review of risk 

posed by the applicant as described in 

45 CFR 75.205. 

As required by 45 CFR part 75 

Appendix XII of the Uniform Guidance, 

non-Federal entities (NFEs) are required 

to disclose in FAPIIS any information 

about criminal, civil, and administrative 

proceedings, and/or affirm that there is 

no new information to provide. This 

applies to NFEs that receive Federal 

awards (currently active grants, 

cooperative agreements, and 

procurement contracts) greater than 

$10,000,000 for any period of time 

during the period of performance of an 

award/project. 

Mandatory Disclosure Requirements 

As required by 2 CFR part 200 of the 

Uniform Guidance, and the HHS 

implementing regulations at 45 CFR part 

75, effective January 1, 2016, the IHS 

must require a non-Federal entity or an 

applicant for a Federal award to 

disclose, in a timely manner, in writing, 

to the IHS or pass-through entity, all 

violations of Federal criminal law 

involving fraud, bribery, or gratutity 

violations potentially affecting the 

Federal award. 

Submission is required for all 

applicants and recipients, in writing, to 

the IHS and to the HHS Office of 

Inspector General. 45 CFR 75.113. 

Disclosures must be sent in writing to: 

U.S. Department of Health and Human 

Services, Indian Health Service, 

Division of Grants Management, ATTN: 

Robert Tarwater, Director, 5600 Fishers 

Lane, Mailstop: 09E70, Rockville, MD 

20857. (Include ‘‘Mandatory Grant 

Disclosures’’ in subject line). 

Telephone: (301) 443–5204. 

Fax: (301) 594–0899. 

Email: Robert.Tarwater@ihs.gov. 

AND 

U.S. Department of Health and 

Human Services, Office of Inspector 

General, ATTN: Mandatory Grant 

Disclosures, Intake Coordinator, 330 

Independence Avenue SW, Cohen 

Building, Room 5527, Washington, DC 

20201. 

Website: http://oig.hhs.gov/fraud/ 

reportfraud/index.asp. (Include 

‘‘Manatory Grant Disclosures’’ in subject 

line). 

Fax: (202) 205–0604 (Include 

‘‘Mandatory Grant Disclosures’’ in 

subject line) or 

Email: 

MandatoryGranteeDisclosures@

oig.hhs.gov. 

Failure to make required disclosures 

can result in any of the remedies 

described in 45 CFR 75.371 Remedies 

for noncompliance, including 

suspension or debarment (See 2 CFR 

part 180 and Part 376, and 31 U.S.C. 

3321). 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: Ms. Roselyn 

Tso, Director, Office of Direct Service 

and Contracting Tribes, Indian Health 

Service, 5600 Fishers Lane, Mail Stop: 

08E17, Rockville, MD 20857, 

Telephone: (301) 443–1104, Email: 

roselyn.tso@ihs.gov. 

2. Questions on grants management 

and fiscal matters may be directed to: 

Ms. Vanietta Armstrong, Grants 

Management Specialist, Indian Health 

Service, OMS/DGM, 5600 Fishers Lane, 

Mail Stop: 09E70, Rockville, MD 20857, 

Telephone: (301) 443–4792, Fax: (301) 

594–0899, Email: vanietta.armstrong@

ihs.gov. 

3. Questions on technical systems 

matters may be directed to: Mr. Paul 

Gettys, Grant Systems Coordinator, 5600 

Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857, Telephone: (301) 

443–2114; or the DGM main line (301) 

443–5204, Fax: (301) 594–0899, Email: 

paul.gettys@ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all recipients of cooperative 

agreement and contracts provide a 

smoke-free workplace and promote the 

non-use of all tobacco products. In 

addition, Pubic Law 103–227, the ProChildren Act of 1994, prohibits smoking 

in certain facilities (or in some cases, 

any portion of the facility) in which 

regular or routine education, library, 

day care, health care, or early childhood 

development services are provided to 

children. This is consistent with the 

HHS mission to protect and advance the 

physical and mental health of the 

American people. 

Dated: June 26, 2018. 

Michael D. Weahkee, 

RADM, Assistant Surgeon General, USPHS, 

Acting Director, Indian Health Service. 

[FR Doc. 2018–14426 Filed 7–3–18; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; The Genetic 

Testing Registry 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice, especially 

regarding the estimated public burden 

and associated response time, should be 

directed to the: Office of Management 

and Budget, Office of Regulatory Affairs, 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974, Attention: Desk 

Officer for NIH. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 129 / Thursday, July 5, 2018 / Notices 31411 

the data collection plans and 

instruments, contact: Dr. Dina Paltoo, 

Director, Scientific Data Sharing Policy 

Division, Office of Science Policy, NIH, 

6705 Rockledge Dr., Suite 750, 

Bethesda, MD 20892, or call non-tollfree number (301) 496–9838, or Email 

your request, including your address to: 

SciencePolicy@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on April 2, 2018, page 14018 

(83 FR 14018) and allowed 60 days for 

public comment. No public comments 

were received. The purpose of this 

notice is to allow an additional 30 days 

for public comment. The Office of the 

Director (OD), National Institutes of 

Health, may not conduct or sponsor, 

and the respondent is not required to 

respond to, an information collection 

that has been extended, revised, or 

implemented on or after October 1, 

1995, unless it displays a currently valid 

OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: The Genetic 

Testing Registry, 0925–0651, Expiration 

Date 07/31/2018—EXTENSION, Office 

of the Director (OD), National Institutes 

of Health (NIH). 

Need and Use of Information 

Collection: Clinical laboratory tests are 

available for more than 10,000 genetic 

conditions. The Genetic Testing Registry 

(GTR) provides a centralized, online 

location for test developers, 

manufacturers, and researchers to 

voluntarily submit detailed information 

about the availability and scientific 

basis of their genetic tests. The GTR is 

of value to clinicians by providing 

information about the accuracy, 

validity, and usefulness of genetic tests. 

The GTR also highlights evidence gaps 

where additional research is needed. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

4,198. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

time per 

response 

(in hours) 

Total annual 

burden hour 

Laboratory Personnel Using Bulk Submission ............... Minimal Fields ..... 313 25 18/60 2,348 

Optional Fields.

............................. 313 25 6/60 783 

Laboratory Personnel Not Using Bulk Submission ........ Minimal Fields ..... 64 25 30/60 800 

Optional Fields.

............................. 64 25 10/60 267 

Total ......................................................................... ............................. 377 18,850 ........................ 4,198 

Dated: June 28, 2018. 

Lawrence A. Tabak, 

Principal Deputy Director, National Institutes 

of Health. 

[FR Doc. 2018–14435 Filed 7–3–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Mental Health Services; 

Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA), 

Center for Mental Health Services 

(CMHS) National Advisory Council 

(NAC) will meet on August 1, 2018, 

from 9:00 a.m. to 5:00 p.m. E.D.T. The 

NAC will convene in both open and 

closed sessions on August 1, 2018. 

The closed portion of the meeting will 

include discussion of grant applications 

that were reviewed by SAMHSA’s 

Initial Review Groups, and involves an 

examination of confidential financial 

and business information as well as 

personal information concerning the 

applications. Therefore, the meeting 

will be closed to the public from 9:00 

a.m. to 9:30 a.m., as determined by the 

Assistant Secretary for Mental Health 

and Substance Use, SAMHSA in 

accordance with Title 5 U.S.C. 

§ 552b(c)(4) and (6) and Title 5 U.S.C. 

App. 2, § 10(d). 

The remainder of this meeting will be 

open to the public from 9:30 a.m. to 5:00 

p.m., E.D.T., to include discussion of 

the Center’s policy issues, updates on 

the Interdepartmental Serious Mental 

Illness Coordinating Committee, 

presentations on Suicide Prevention, 

School Mental Health/Child Trauma 

and a conversation with the Assistant 

Secretary for Mental Health and 

Substance Use. 

Attendance by the public will be 

limited to available space. Interested 

persons may present data, information, 

or views, orally or in writing, on issues 

pending before the council. Written 

submissions should be forwarded to the 

contact person (below) on or before July 

17, 2018. Oral presentations from the 

public will be scheduled at the 

conclusion of the meeting on 

Wednesday, August 1, 2018. Five 

minutes will be allotted for each 

presentation. Meeting information and a 

roster of Council members may be 

obtained either by accessing the 

SAMHSA Council website at http://

www.samhsa.gov/about-us/advisorycouncils/cmhs-national-advisorycouncil or by contacting Ms. Pamela 

Foote (see contact information below). 

The meeting can be accessed via 

telephone. To obtain the conference 

call-in number and access code, submit 

written or brief oral comments, or 

request special accommodations for 

persons with disabilities, please register 

at the SAMHSA’s Advisory Council 

website at http://nac.samhsa.gov/ 

Registration/meetingsRegistration.aspx, 

or contact Pamela Foote (see contact 

information below). 

Committee Name: Substance Abuse 

and Mental Health Services 

Administration Center for Mental 

Health Services National Advisory 

Council. 

Dates/Time/Type: Wednesday, 

August 1, 2018, 9:00 a.m. to 9:30 a.m. 

EDT: CLOSED; Wednesday, August 1, 

2018, 9:30 a.m. to 5:00 p.m. EDT: OPEN. 

Place: SAMHSA, 5600 Fishers Lane, 

5th Floor, Conference Room 5W11, 

Rockville, Maryland 20857. 


amozie on DSK3GDR082PROD with NOTICES1